What Artrinid Treats: Main Uses and Benefits

The primary therapeutic role of Artrinid (Ketoprofen) is to provide symptomatic relief for symptoms related to physical discomfort and heightened physiological activity across a range of clinical presentations. It is used to moderate distressing manifestations and offers supportive therapeutic benefit in situations where symptoms interfere with daily functioning. Prescription ketoprofen is commonly used to help with pain, tenderness, swelling, and stiffness caused by osteoarthritis and rheumatoid arthritis. It is also relevant for easing pain, including menstrual pain.

---

Artrinid is generally applied in conditions characterized by periods of heightened symptoms, such as the chronic discomfort of inflammatory joint disorders, acute pain following soft tissue injuries like sprains and strains, and intense episodic pain associated with primary dysmenorrhea. It is relevant in clinical settings that involve acute or unstable symptom patterns where temporary functional strain is present.

“The application of Artrinid in these contexts provides support that helps ease the overall symptom burden, contributing to comfort during periods where symptoms intensify.”

Quick Fact: Relief for Pain and Discomfort

Category	Typical Symptoms Managed
Chronic Conditions	Symptoms of joint pain, swelling, and stiffness associated with rheumatoid and osteoarthritis.
Acute Contexts	Symptoms of pain and strain following injury, post-operative discomfort, and gout flares.
Episodic Relief	Symptoms of severe menstrual cramps (primary dysmenorrhea) and fever.

---

The medication may assist with maintaining functional stability and supports patients during difficult episodes by easing distress, and may be part of symptomatic management in situations where patients experience distressing symptom manifestations.

Regulatory References

1. NIH MedlinePlus Drug Information

The eligibility for Artrinid (Ketoprofen) is strictly determined by regulatory authorities, who define specific populations that must not use the medicine and others who require conditional use.

Contraindicated Populations (Must Not Use)

• Allergy/Sensitivity: Patients with known hypersensitivity to Ketoprofen, Aspirin, or any other NSAID (Nonsteroidal Anti-inflammatory Drug), including those with a history of asthma or rhinitis triggered by these substances.
• Active Disease: Individuals with active peptic ulcers, active gastrointestinal bleeding, or severe uncontrolled heart or renal failure.
• Surgical Context: Treatment of pain related to Coronary Artery Bypass Graft (CABG) surgery.

---

Restricted and Conditional Use

Population Group	Official Regulatory Status
Late Pregnancy	Contraindicated in the third trimester (from 30 weeks gestation).
Pediatric Patients	Safety and efficacy have not been established for systemic use in children; generally not recommended under 15 years of age.
Elderly (Geriatric)	Use with caution and close monitoring; often requires a lower initial maximum daily dose.
Organ Impairment	Requires close monitoring and dose reduction in cases of moderate renal or hepatic impairment.

Interactions with other medicines and products

Artrinid, which contains Ketoprofen, an NSAID, has officially documented interaction patterns that are primarily categorized by the risk of bleeding or by alterations in the clearance of co-administered medicines, as stated in regulatory labels.

---

Official Interaction Restrictions

Classification	Interacting Substances / Categories
Contraindicated Combinations	Oral Anticoagulants (e.g., Warfarin), other NSAIDs (including COX-2 inhibitors and high-dose salicylates), and Methotrexate at doses greater than 15 mg per week.
Clinically Significant Risk	Diuretics, ACE Inhibitors, Angiotensin II Receptor Blockers (ARBs), Lithium, Cardiac Glycosides, Ciclosporin, Tacrolimus.

---

Documented Interaction Outcomes

• Increased Risk of Hemorrhage: Co-administration with Antiplatelet agents (e.g., Clopidogrel), SSRIs, or Corticosteroids officially leads to an additive risk of gastrointestinal bleeding or ulceration.
• Altered Exposure: Ketoprofen reduces the renal clearance of substances like Lithium and Methotrexate (low dose), leading to elevated plasma concentrations of those medicines. Conversely, Probenecid causes a pharmacokinetic interaction that significantly increases Ketoprofen exposure.
• Substance Constraints: Regulatory labels note that concurrent use of alcohol officially increases the risk of gastrointestinal bleeding.

---

Population-Specific Note

Official labeling documents that the risk and severity of gastrointestinal bleeding and renal toxicity are increased in elderly patients when Ketoprofen is co-administered with certain agents, such as anticoagulants and diuretics.

Enzyme Inhibition in the Prostaglandin Synthesis Cascade

The core mechanism of Artrinid (Ketoprofen) involves the reversible, non-selective inhibition of Cyclooxygenase (COX) enzymes, targeting both the constitutive COX-1 and the inducible COX-2 isoforms. This interaction blocks the enzyme active site, halting the fundamental molecular step of converting Arachidonic Acid into prostaglandins . This physiological suppression of prostaglandin production leads to decreased local vascular permeability and resets an elevated body temperature set-point within the central nervous system.

---

Integrated Modulation of Pain Signaling Pathways

Beyond COX inhibition, the molecule engages complementary mechanisms that influence pain signaling and lysosomal membrane stabilization. This includes inhibition of mediators like Bradykinin and modulation within central serotonergic pathways, supporting a dual peripheral and central modulation of nociceptive signaling. Furthermore, the molecule acts to stabilize lysosomal membranes and exhibits secondary inhibitory effects on the Lipoxygenase (LOX) pathway. These actions collectively limit the impact of destructive enzymes and alternative inflammatory mediators, contributing to the overall physiological activity.

Official Administration Guidelines for Artrinid (Ketoprofen)

Artrinid, containing Ketoprofen, is administered via the oral route, using capsules or tablets, or via the topical (dermal) route, typically as a gel or cream. The official instructions for use are determined by the specific formulation and the governing regulatory authority.

---

Administration Scope

Feature	Official Labeled Instruction
Route of Administration	Oral or Topical (Dermal)
Dosing Schedule	Immediate-release (IR) forms are taken in divided doses, not to exceed 300 mg per day. Extended-release (ER) forms are generally taken 200 mg once daily
Timing in Relation to Meals	Oral formulations may be taken with food, milk, or an antacid; this can help mitigate discomfort but may slow the absorption rate
Age-Group Rules	Dosing for older adults should be initiated at the lower end of the recommended range; safety and efficacy in pediatric patients are not established
Missed-Dose Rule	If a dose is missed, the user should skip the missed dose and resume the regular schedule; do not take a double dose

---

Use-Context Constraints

All use must adhere to the principle of employing the lowest effective dose for the shortest possible duration. The extended-release formulation is not recommended for the treatment of acute pain. For topical application, the preparation must be gently massaged onto the affected area and is not for use with occlusive dressings or on broken skin. Adjustments to the maximum dose (e.g., 100 mg/day for severe renal impairment) are required when hepatic or renal function is compromised.

Research Evidence / Overview of Studies for Artrinid (Ketoprofen)

Evidence for Use in Chronic Inflammatory Joint Conditions

The research base for conditions like Osteoarthritis (OA) and Rheumatoid Arthritis (RA) includes numerous short-to-intermediate term Randomized Controlled Trials (RCTs) and large Systematic Reviews. These studies monitored adults and older adults diagnosed with the condition. Artrinid was evaluated in relation to a placebo or other existing Nonsteroidal Anti-inflammatory Drugs (NSAIDs) to explore its characteristics in a research setting. Researchers measured changes in pain intensity and daily functioning using validated instruments. Studies report patterns observed in these measured changes over defined time intervals.

Evidence for Use in Acute Pain and Post-Surgical Discomfort

Research exploring short-term symptom changes, such as pain after a surgical procedure, relies on standardized, single-dose, placebo-controlled trials. These studies were observed in adults experiencing moderate-to-severe acute pain. The outcomes monitored centered on the timing and extent of acute changes, such as the time until patients reported a noticeable change in their pain level. These findings describe patterns observed in the immediate hours following administration.

Evidence for Use in Localized Soft Tissue Injury and Pain

For localized symptoms associated with minor soft tissue injury, research has examined topical formulations through Randomized, Double-Blind, Placebo-Controlled Trials. These studies monitored adults with conditions like sprains or tendonitis. The outcomes examined related to physical discomfort at the application site, with researchers measuring changes in localized pain when patients were moving or at rest.

Key Areas of Research Uncertainty

The broader evidence landscape contributes to understanding symptom patterns, but key areas of research uncertainty are noted. The primary uncertainty lies with long-term effects, as follow-up durations were limited in many core efficacy studies (often up to 12 weeks). Furthermore, data for certain groups remain insufficient, specifically for patients with complex concurrent health issues, as these individuals were typically excluded from the primary trials. Research highlights what is known and what is still uncertain.

Key Studies & References

1. Ketoprofen: MedlinePlus Drug Information (for main uses, dosage forms, and indications)
2. World Health Organization (WHO) ATC/DDD Index: Ketoprofen (for pharmacological class and general classification)

Common questions about Artrinid (FAQ)

Q: Is it common to feel dizzy when first taking Artrinid?

Official product information indicates that side effects affecting the nervous system, such as dizziness or drowsiness, may be more pronounced when treatment is first initiated. These effects may also be stronger following an adjustment to the dosage. This pattern is noted in regulatory documentation describing the medicine's activity.

Q: Does Artrinid interact with common over-the-counter medicines like cold remedies?

Regulatory warnings advise caution regarding co-administering Artrinid with other medicines. Specifically, using it alongside other nonsteroidal anti-inflammatory drugs (NSAIDs) or blood-thinning agents, which are often contained in over-the-counter products, may increase certain risks. Information in the official label describes checking product ingredients to help avoid overlapping drug categories.

Q: Is Artrinid taken long-term or short-term?

Regulatory guidance is clear that Artrinid should be used for the shortest possible duration. This is because the potential risk for serious adverse events, particularly cardiovascular or gastrointestinal issues, is noted to increase with the length of use. The principle described in regulatory guidance is that the lowest effective dose is used for the shortest duration necessary to manage symptoms.

Q: Are there any specific foods or drinks to avoid while using Artrinid?

Oral formulations of Artrinid may be taken with food, milk, or an antacid, and taking it this way can help lessen stomach upset. Regarding beverages, official warnings specifically note that concurrent use of alcohol increases the risk of gastrointestinal bleeding. There are no general prohibitions on other specific food groups described in labeling.

Q: Is there a maximum time frame for how long Artrinid can be used?

Regulatory documentation for acute pain relief formulations, such as the 12.5 mg oral soluble film, outlines specific maximum time frames. For example, for this specific dose, a maximum treatment duration of 10 days for pain relief and 3 days for fever is recommended. The appropriate duration for prescription use is managed by the treating health professional.

Q: Can I drive or operate machinery after taking Artrinid?

Official warnings state that Artrinid may temporarily affect a user's ability to drive or operate machinery. This is because the medicine can cause side effects like drowsiness and dizziness. Official warnings state that activities requiring mental alertness, such as driving, should not be performed until the individual knows how the medicine affects them.

Q: How quickly does Artrinid start working?

The time it takes for a medicine to begin acting depends on the specific formulation. For example, the oral soluble film is documented to disintegrate in the mouth within approximately 10 to 15 seconds, allowing for rapid absorption. This rapid disintegration contributes to the medicine's overall timely action profile.

Q: Is Artrinid addictive?

Artrinid, which contains Ketoprofen, is formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). It is not classified as a controlled substance by regulatory agencies and is not known to be associated with the potential for addiction or dependence.

Q: Does Artrinid affect blood pressure?

Official safety information lists increased blood pressure (hypertension) as a reported side effect of the medicine. This is a potential effect noted in the safety profile.

Q: Does Artrinid require a prescription?

Artrinid is available in different regulatory statuses depending on its dosage strength and formulation. The medicine can be found in both prescription-strength (Rx) and over-the-counter (OTC) formulations, according to the regulatory guidelines of the specific country.

Q: Are the effects of Artrinid permanent?

Regulatory documents state that Artrinid works to relieve symptoms as long as it is being used. It is not designed to cure chronic conditions or prevent their progression, meaning its effects on symptoms are temporary and cease upon discontinuing the medicine.

Q: Can Artrinid be used to treat headaches?

Regulatory documentation for certain formulations, particularly those available over the counter, lists the medicine for the temporary relief of minor aches and pains. This includes discomfort due to conditions such as headache.

Q: What should I do if a side effect seems severe?

Official labeling describes that severe side effects necessitate immediate cessation of the medication and prompt emergency medical attention. Users are also advised to report all serious or unexpected adverse reactions to their health professional.

Q: What does Artrinid treat besides the main condition?

The officially approved indications for Artrinid include the treatment of signs and symptoms of inflammatory joint conditions like osteoarthritis and rheumatoid arthritis. It is also approved for conditions such as primary dysmenorrhea (menstrual pain) and the relief of mild-to-moderate acute pain.

Q: What is the half-life of Artrinid?

The half-life is a measure of how quickly the medicine is cleared from the body. According to official pharmacokinetic data, the average plasma elimination half-life of Ketoprofen is approximately 2 to 4 hours.

Q: Are there different strengths of Artrinid available?

The active ingredient is available in multiple strengths to accommodate different dosing needs. It is manufactured in various oral forms, including immediate-release (IR) and extended-release (ER) formulations, each available in different milligram amounts.

Q: Does Artrinid show up on drug tests?

Studies cited in clinical literature have indicated that Ketoprofen may cause false positive results for cannabis (THC) on certain routine urine drug screening tests. This possibility is described in literature regarding cross-reactivity during certain screening procedures.

Q: Can Artrinid cause changes in mood?

Official safety information includes reports of mental/mood changes and psychiatric side effects. These reported effects can include feelings such as irritability or feeling sad or empty.

Q: What are the signs of an allergic reaction to Artrinid?

Signs of a serious allergic reaction documented in official information may include rash, fever, swelling (of the face or throat), severe dizziness, and trouble breathing. This medication is contraindicated for individuals with a known sensitivity to NSAIDs.

Q: What does 'contraindication' mean in the context of Artrinid?

A contraindication is a core technical term used in official documents to describe a situation or condition where the medication must not be used. This restriction is in place because the potential risk of harm to the patient is judged to outweigh any potential benefit.

How to Store and Dispose of Artrinid

The official regulatory labeling defines strict requirements for the storage and disposal of Artrinid (Ketoprofen) to maintain product integrity and safety.

Storage Requirements

Artrinid must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The medicine must be protected from excessive heat, moisture, and direct light and must be kept from freezing at all times. The container should be kept tightly closed and must utilize a child-resistant closure. It is mandatory to keep the product out of the reach of children and pets.

Disposal Instructions

Unused or expired Artrinid should preferably be discarded through an official drug take-back program or collection site. If a take-back program is unavailable, the medicine must be removed from its container, mixed with an unappealing substance (such as dirt or used coffee grounds), placed in a sealed bag, and discarded in the household trash. The medication must not be flushed down the sink or toilet.